More Investment in Parkinson's Genetics Research | FoxFlash August 2016

Another Company  Focuses on the Promise  of LRRK2 Drug Discovery

LRRK2 is one of the most important drug targets in Parkinson's research. In promising news, a San Francisco biotech recently announced the development of a therapeutic program for the LRRK2 gene. Forbes covered the story and featured the Foundation's role in this new effort.

Read More >

How Doctors Choose Parkinson's Medications
Hear expert discussion, and ask questions in our Third Thursdays Webinar series.
September 15 at 12 p.m. ET

Urge Congress to Support PD Research Now is an important time to contact your congressional representatives before they return to Washington D.C. in September. Read more on the latest PD policy issues and tools for emailing members of Congress. Read More >

Can Virtual Reality Help Prevent Falls with Parkinson's? PD falls are common and serious. MJFF-funded research has shown how virtual reality could help people living with Parkinson's improve cognition and motor skills to avoid falls. Read More >

Team Fox Fall Fundraising: Pumpkin Spice and Everything Nice Pumpkin carvings, costume contests and back-to-school pancake breakfasts are only a few ideas to fundraise in support of a cure this autumn. Put your passions (and creativity!) to use with Team Fox this season. Read More >

Podcast: The Dystopian Experience of Dystonia As we near Dystonia Awareness Month in September, listen to a podcast to learn more about dystonia, the third most common movement disorder, and one woman's mission to raise visibility of the condition. Read More >

Join MJFF at the World Parkinson's  Congress in Portland From September 20 to 23, the Foundation will attend the fourth annual World Parkinson's Congress (WPC) in Portland, Oregon. Learn more about WPC and visit us at booth #407 during the event. Read More >